Fiedler W. Therapy with hypomethlyating agents/venetoclax in patients with newly diagnosed
acute myeloid leukaemia requiring admission to the intensive care unit: Possible
reduction in side effects with preserved efficacy. Br J Haematol 2024;204:1135-1136.
PMID: 38228122